Position in INSM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$14,659,077
-$611,192 QoQ
Shares Held
89,647
+2.2% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Treasurer of the State of North Carolina holds $227,922,242 across 22 Biotechnology names. INSM ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,663 | $48,522,376 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,382 | $46,653,548 | |
| 3 | RPRX |
Royalty Pharma plc
|
544,033 | $26,097,263 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,269 | $17,955,984 | |
| 5 | INSM |
INSMED Inc
This page
|
89,647 | $14,659,077 | |
| 6 | INCY |
Incyte Corp
|
136,241 | $12,823,002 | |
| 7 | EXEL |
Exelixis, Inc.
|
276,296 | $11,850,335 | |
| 8 | MRNA |
Moderna, Inc.
|
153,407 | $7,793,075 |
All Filings in INSM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,659,077 | 89,647 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,270,269 | 87,740 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,061,125 | 83,752 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,392,369 | 83,390 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $2,883,800 | 41,770 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,102,500 | 42,500 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||